Inhaled Nitric Oxide Market
- 2026 年市場規模
- USD 1,667.6 Mn
- 2033 年預估規模
- USD 3,021.4 Mn
- 年複合成長率 CAGR
- 8.9%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Inhaled Nitric Oxide Market, By Product Type (Inhaled Nitric Oxide Delivery Systems and Consumables), By Age Group (Neonates, Pediatrics, and Adults), By Application (Neonatal Respiratory Treatment (Persistent Pulmonary Hypertension of the Newborn), Acute Respiratory Distress Syndrome (ARDS), Pulmonary Hypertension, Surgery and Postoperative Management, and Others), By End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The global Inhaled nitric oxide market is estimated to be valued at USD 1,667.6 Mn in 2026 and is expected to reach USD 3,021.4 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033. Inhaled nitric oxide is an agent that acts selectively as a vasodilator for the lungs, it relaxes the pulmonary vasculature, thus improving the blood flow into areas of good ventilation. This drug is administered mainly in intensive care settings and is commonly used in the management of neonatal hypoxic respiratory failure due to persistent pulmonary hypertension of the newborns. It is also indicated in acute respiratory distress syndrome, pulmonary hypertension, and complications from cardiac and thoracic surgeries. Respiratory diseases have been on the increase, while the dependence on intensive care medicine has also grown in the health care sector.
Inhaled nitric oxide administration systems are experiencing innovations related to their mobility, dose accuracy, and ventilator compatibility. The move towards tank-free and demand-based systems for nitric oxide production can help in making the technology easily accessible while overcoming limitations arising from the handling of nitric oxide gas cylinders. Besides, the development of neonatal and ICU facilities in the developing nations is contributing positively to market dynamics. Yet, high costs involved and the presence of other respiratory management therapies pose restrictions in the market penetration of nitric oxide products. Nevertheless, the potential applications discovered through current clinical studies should be sufficient to ensure future growth in this market.
Market Dynamics
The global inhaled nitric oxide market has witnessed a significant growth due to the growing prevalence of critical respiratory illnesses and the use of intensive care treatment methods. The therapy is widely accepted and recognized as an effective means of oxygenating critical patients who suffer from respiratory distress. The increasing numbers of babies born prematurely and neonatal intensive care units are some of the factors that have been contributing to a consistent increase in the demand for the product. Furthermore, the growing prevalence of respiratory distress syndrome, pulmonary hypertension, and cardiopulmonary disorders is playing an instrumental role in driving the uptake of inhaled nitric oxide.
However, several aspects could hinder the market from experiencing any significant expansion. These include the expensive nature of treatment and equipment, making it difficult for users in healthcare facilities with cost constraints to afford. Besides, there are other techniques available in the industry that act as competition in providing alternatives to assist patients in respiration and other medical conditions. Other challenges include the difficulties in storing and transporting gases, which can be an obstacle in adopting the technology in some health facilities. However, several promising trends exist within the industry, such as the emergence of portable and tankless methods for delivering nitric oxide. This trend will overcome some barriers to adoption within the market, especially those concerning storage and portability.
Key Features of the Study
• This report provides in-depth analysis of the global inhaled nitric oxide market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global inhaled nitric oxide market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Mallinckrodt Pharmaceuticals, Linde plc, Air Liquide, VERO Biotech, Beyond Air, Bellerophon Therapeutics, Getinge AB, Nu-Med Plus, International Biomedical, and Messer Group
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global inhaled nitric oxide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhaled nitric oxide market
Market Segmentation
• Product Type Insights (Revenue, USD Mn, 2021 - 2033)
o Inhaled Nitric Oxide Delivery Systems
o Consumables
• Age Group Insights (Revenue, USD Mn, 2021 - 2033)
o Neonates
o Pediatrics
o Adults
• Application Insights (Revenue, USD Mn, 2021 - 2033)
o Neonatal Respiratory Treatment (Persistent Pulmonary Hypertension of the Newborn)
o Acute Respiratory Distress Syndrome (ARDS)
o Pulmonary Hypertension
o Surgery and Postoperative Management
o Others
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o Hospitals
o Ambulatory Surgical Centers
o Home Care Settings
o Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Mallinckrodt Pharmaceuticals
o Linde plc
o Air Liquide
o VERO Biotech
o Beyond Air
o Bellerophon Therapeutics
o Getinge AB
o Nu-Med Plus
o International Biomedical
o Messer Group
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Inhaled Nitric Oxide Market, By Product Type
Global Inhaled Nitric Oxide Market, By Age Group
Global Inhaled Nitric Oxide Market, By Application
Global Inhaled Nitric Oxide Market, By End User
Global Inhaled Nitric Oxide Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trends
4. Global Inhaled Nitric Oxide Market, By Product Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Inhaled Nitric Oxide Delivery Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Consumables
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Inhaled Nitric Oxide Market, By Age Group, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Neonates
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Pediatrics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Adults
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Inhaled Nitric Oxide Market, By Application, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Neonatal Respiratory Treatment (Persistent Pulmonary Hypertension of the Newborn)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Acute Respiratory Distress Syndrome (ARDS)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Pulmonary Hypertension
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Surgery and Postoperative Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Inhaled Nitric Oxide Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Home Care Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Inhaled Nitric Oxide Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
9. Competitive Landscape
o Mallinckrodt Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Linde plc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Air Liquide
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o VERO Biotech
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Beyond Air
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Bellerophon Therapeutics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Getinge AB
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Nu-Med Plus
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o International Biomedical
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Messer Group
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
10. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
11. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on 'Inhaled Nitric Oxide Market' - Global forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們